SIMILAR PATTERNS OF AMINO ACIDS FOR 5HA9_B_TP0B406
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1efy | POLY (ADP-RIBOSE)POLYMERASE (Gallus gallus) |
PF00644(PARP)PF02877(PARP_reg) | 8 | ASP A 770HIS A 862SER A 864ASN A 868ILE A 872TYR A 896SER A 904TYR A 907 | NoneBZC A 201 (-4.0A)NoneNoneNoneBZC A 201 (-4.0A)BZC A 201 (-3.3A)BZC A 201 (-3.6A) | 0.55A | 5ha9B-1efyA:50.7 | 5ha9B-1efyA:86.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2e7z | ACETYLENE HYDRATASEAHY (Pelobacteracetylenicus) |
PF00384(Molybdopterin)PF01568(Molydop_binding) | 5 | ASP A 298HIS A 149ASN A 144ILE A 307SER A 155 | None | 1.30A | 5ha9B-2e7zA:undetectable | 5ha9B-2e7zA:18.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pqf | POLY [ADP-RIBOSE]POLYMERASE 12 (Homo sapiens) |
PF00644(PARP) | 5 | HIS A 564ILE A 574TYR A 596SER A 604TYR A 607 | GAB A 701 ( 3.7A)CIT A 801 (-4.8A)GAB A 701 (-4.5A)GAB A 701 (-2.8A)GAB A 701 (-3.3A) | 0.76A | 5ha9B-2pqfA:16.8 | 5ha9B-2pqfA:22.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3c49 | POLY(ADP-RIBOSE)POLYMERASE 3 (Homo sapiens) |
PF00644(PARP)PF02877(PARP_reg) | 5 | HIS A 384ILE A 394TYR A 414SER A 422TYR A 425 | KU8 A 601 (-4.0A)NoneKU8 A 601 (-4.1A)KU8 A 601 (-2.9A)KU8 A 601 (-3.5A) | 0.48A | 5ha9B-3c49A:40.8 | 5ha9B-3c49A:37.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hkv | POLY [ADP-RIBOSE]POLYMERASE 10 (Homo sapiens) |
PF00644(PARP) | 5 | HIS A 887ILE A 897TYR A 919SER A 927TYR A 932 | 3AB A1025 (-3.8A)None3AB A1025 (-4.4A)3AB A1025 (-2.8A)3AB A1025 (-3.7A) | 0.75A | 5ha9B-3hkvA:16.5 | 5ha9B-3hkvA:19.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3u4t | TPRREPEAT-CONTAININGPROTEIN (Cytophagahutchinsonii) |
PF07719(TPR_2) | 5 | GLU A 428ASN A 471ILE A 472TYR A 451TYR A 456 | None | 1.25A | 5ha9B-3u4tA:undetectable | 5ha9B-3u4tA:20.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4f0d | POLY [ADP-RIBOSE]POLYMERASE 16 (Homo sapiens) |
PF00644(PARP) | 6 | HIS A 152SER A 154ASN A 158ILE A 162TYR A 182TYR A 193 | 3AB A 301 (-4.0A)NoneNoneNone3AB A 301 (-4.3A)3AB A 301 (-3.8A) | 0.72A | 5ha9B-4f0dA:11.9 | 5ha9B-4f0dA:25.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4l2k | TANKYRASE-2 (Homo sapiens) |
PF00644(PARP) | 6 | HIS A1031SER A1033ILE A1039TYR A1060SER A1068TYR A1071 | 1V8 A1201 (-4.2A)1V8 A1201 (-3.2A)None1V8 A1201 (-4.7A)1V8 A1201 (-2.7A)1V8 A1201 (-3.3A) | 0.66A | 5ha9B-4l2kA:10.1 | 5ha9B-4l2kA:21.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oa7 | TANKYRASE-1 (Homo sapiens) |
PF00644(PARP) | 5 | HIS A1184ILE A1192TYR A1213SER A1221TYR A1224 | 2XS A1402 (-4.2A)2XS A1402 ( 4.7A)2XS A1402 (-4.2A)None2XS A1402 ( 3.9A) | 0.96A | 5ha9B-4oa7A:17.8 | 5ha9B-4oa7A:22.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oa7 | TANKYRASE-1 (Homo sapiens) |
PF00644(PARP) | 5 | SER A1186ILE A1192TYR A1213SER A1221TYR A1224 | 2XS A1402 (-3.6A)2XS A1402 ( 4.7A)2XS A1402 (-4.2A)None2XS A1402 ( 3.9A) | 0.92A | 5ha9B-4oa7A:17.8 | 5ha9B-4oa7A:22.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homo sapiens) |
PF00644(PARP)PF02877(PARP_reg)PF05406(WGR) | 6 | ASP C 770SER C 864ASN C 868ILE C 872SER C 904TYR C 907 | NoneNoneNoneNone2US C1101 (-3.4A)2US C1101 (-3.5A) | 0.86A | 5ha9B-4oqaC:46.1 | 5ha9B-4oqaC:86.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4oqa | POLY [ADP-RIBOSE]POLYMERASE 1 (Homo sapiens) |
PF00644(PARP)PF02877(PARP_reg)PF05406(WGR) | 7 | HIS C 862SER C 864ASN C 868ILE C 872TYR C 896SER C 904TYR C 907 | 2US C1101 (-3.7A)NoneNoneNone2US C1101 (-4.2A)2US C1101 (-3.4A)2US C1101 (-3.5A) | 0.47A | 5ha9B-4oqaC:46.1 | 5ha9B-4oqaC:86.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xru | HEN1 (Capnocytophagagingivalis) |
no annotation | 5 | ASP C 188HIS C 176ILE C 187SER C 72TYR C 57 | None | 1.40A | 5ha9B-4xruC:undetectable | 5ha9B-4xruC:22.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4zzy | POLY [ADP-RIBOSE]POLYMERASE 2 (Homo sapiens) |
PF00644(PARP)PF02877(PARP_reg) | 7 | HIS A 428SER A 430ASN A 434ILE A 438TYR A 462SER A 470TYR A 473 | D7N A1584 (-3.6A)NoneNoneNoneD7N A1584 (-3.7A)D7N A1584 (-2.7A)D7N A1584 (-3.8A) | 0.46A | 5ha9B-4zzyA:43.8 | 5ha9B-4zzyA:45.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ck7 | ADP-DEPENDENTGLUCOKINASE (Mus musculus) |
PF04587(ADP_PFK_GK) | 5 | GLU A 327ASP A 480HIS A 295ASN A 159ILE A 163 | NoneAMP A 601 ( 4.9A)NoneNoneNone | 1.47A | 5ha9B-5ck7A:undetectable | 5ha9B-5ck7A:21.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ck7 | ADP-DEPENDENTGLUCOKINASE (Mus musculus) |
PF04587(ADP_PFK_GK) | 5 | GLU A 327ASP A 480SER A 261ASN A 159ILE A 163 | NoneAMP A 601 ( 4.9A)NoneNoneNone | 1.43A | 5ha9B-5ck7A:undetectable | 5ha9B-5ck7A:21.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dcz | TANKYRASE-2 (Homo sapiens) |
PF00644(PARP) | 6 | HIS A1031SER A1033ILE A1039TYR A1060SER A1068TYR A1071 | 59B A1203 (-4.1A)59B A1203 (-3.5A)None59B A1203 (-4.3A)59B A1203 (-2.8A)59B A1203 (-3.3A) | 0.65A | 5ha9B-5dczA:17.4 | 5ha9B-5dczA:22.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dsy | POLY [ADP-RIBOSE]POLYMERASE 2 (Homo sapiens) |
PF00644(PARP) | 7 | HIS A 415SER A 417ASN A 421ILE A 425TYR A 449SER A 457TYR A 460 | UHB A1001 (-3.7A)UHB A1001 (-2.5A)UHB A1001 (-3.7A)UHB A1001 (-4.6A)UHB A1001 (-3.8A)UHB A1001 (-2.5A)UHB A1001 (-3.4A) | 0.53A | 5ha9B-5dsyA:32.8 | 5ha9B-5dsyA:40.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lx6 | POLY [ADP-RIBOSE]POLYMERASE 10 (Homo sapiens) |
PF00644(PARP) | 5 | HIS A 887ILE A 897TYR A 919SER A 927TYR A 932 | 78P A1101 (-4.0A)None78P A1101 (-3.7A)78P A1101 (-2.8A)78P A1101 (-3.8A) | 0.84A | 5ha9B-5lx6A:16.5 | 5ha9B-5lx6A:20.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5xst | POLY [ADP-RIBOSE]POLYMERASE 1 (Homo sapiens) |
no annotation | 8 | GLU A 102ASP A 109HIS A 201SER A 203ASN A 207ILE A 211SER A 243TYR A 246 | 8E6 A 401 (-4.2A)None8E6 A 401 (-3.5A)NoneNoneNone8E6 A 401 (-2.6A)8E6 A 401 (-3.4A) | 0.80A | 5ha9B-5xstA:49.2 | 5ha9B-5xstA:98.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5xst | POLY [ADP-RIBOSE]POLYMERASE 1 (Homo sapiens) |
no annotation | 7 | HIS A 201SER A 203ASN A 207ILE A 211TYR A 235SER A 243TYR A 246 | 8E6 A 401 (-3.5A)NoneNoneNone8E6 A 401 (-4.1A)8E6 A 401 (-2.6A)8E6 A 401 (-3.4A) | 0.51A | 5ha9B-5xstA:49.2 | 5ha9B-5xstA:98.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6bhv | POLY [ADP-RIBOSE]POLYMERASE 1 (Homo sapiens) |
no annotation | 7 | HIS A 862SER A 864ASN A 868ILE A 872TYR A 896SER A 904TYR A 907 | DQV A1101 (-3.6A)DQV A1101 (-2.9A)DQV A1101 (-4.2A)DQV A1101 (-4.5A)DQV A1101 (-3.5A)DQV A1101 (-2.7A)DQV A1101 (-3.7A) | 0.47A | 5ha9B-6bhvA:35.3 | 5ha9B-6bhvA:31.32 |